Table of Contents Table of Contents
Previous Page  20 / 168 Next Page
Information
Show Menu
Previous Page 20 / 168 Next Page
Page Background

1.3

I

LISI MEDICAL

€137.0 million

SALES REVENUE

8%of consolidated sales revenue

909

STAFF

8%of Group headcount

€11 million

CAPEX

8%of total Group CAPEX

Activity

Medical implant and auxiliary

parts subcontractor

Flagship products

Joint reconstruction:

orthopedic reconstruction

implants and instruments (hip,

shoulder, knee).

Spine, extremities, trauma and

dental:

orthopedic implants and

instruments, trauma and

extremities, spine, maxillofacial

and dental.

Mini-invasive single-use

instruments:

vascular, gastro intestinal,

urology.

Customers

Alphatech;

Ace Surgical;

Boston Scientific;

C2F Implants;

Integra Lifescience;

Intuitive Surgical;

Johnson & Johnson and

subsidiaries;

Medacta;

Medicrea;

Medtronic;

Signature Orthopaedics;

Smith & Nephew;

Spineway;

Stryker;

Zimmer-Biomet;

Wright Tornier.

Competitors

Accelent;

Avalign;

CoorsTek;

Integer;

Marle;

Norwood;

Orchid/Sandvik;

Paragon;

Tecomet;

Tegra.

MINIMALLY INVASIVE

SURGERY INSTRUMENTS

INSTRUMENTS

VASCULAR

IMPLANTS

UPPER EXTREMITIES

IMPLANTS

MAXILLOFACIAL IMPLANTS

TRAUMATOLOGY

IMPLANTS

TOTAL KNEE

PROSTHESIS

LOWER EXTREMITIES

IMPLANTS

SPINAL

IMPLANTS

TOTAL HIP

PROSTHESIS

UPPER EXTREMITIES

IMPLANTS

DENTAL IMPLANTS

LISI MEDICAL is involved in the design, manufacturing and marketing phases of all above-mentioned products. LISI MEDICAL is positioned as a

subcontractor.

Themain rawmaterials used are the following: titanium, chromium, cobalt, plastic (PEEK, PEHT), etc.

Themain technologies used are lathing, milling, forging, packaging under sterile conditions, laser marking and special processes.

20

LISI 2017 FINANCIAL REPORT

FINANCIAL SITUATION

2